Novartis AG (NVSN) — Cash Flow Quality Index
Novartis AG (NVSN) has a Cash Flow Quality Index of 1.16x as of March 2026. Operating cash flow of MX$3.68 Billion exceeds net income of MX$3.16 Billion, indicating high earnings quality where cash backs reported profits. Explore Novartis AG (NVSN) long-term investment share to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Novartis AG Cash Flow Quality Index (2014–2025)
Historical Cash Flow Quality Index for Novartis AG across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible net worth ratio of Novartis AG to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Novartis AG (2014–2025)
Year-by-year earnings quality comparison for Novartis AG. For live market cap and the full company financial profile, see market cap of Novartis AG.
| Year | Quality Index | Operating CF (MXN) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.37x | MX$19.14 Billion | MX$13.98 Billion | ▼ -7.2% |
| 2024 | 1.48x | MX$17.62 Billion | MX$11.94 Billion | ▲ +36.8% |
| 2023 | 1.08x | MX$16.02 Billion | MX$14.85 Billion | ▼ -47.3% |
| 2022 | 2.05x | MX$14.24 Billion | MX$6.96 Billion | ▲ +226.2% |
| 2021 | 0.63x | MX$15.07 Billion | MX$24.02 Billion | ▼ -62.9% |
| 2020 | 1.69x | MX$13.65 Billion | MX$8.07 Billion | ▲ +45.6% |
| 2019 | 1.16x | MX$13.62 Billion | MX$11.73 Billion | ▲ +2.6% |
| 2018 | 1.13x | MX$14.27 Billion | MX$12.61 Billion | ▼ -30.9% |
| 2017 | 1.64x | MX$12.62 Billion | MX$7.70 Billion | ▼ -4.2% |
| 2016 | 1.71x | MX$11.47 Billion | MX$6.71 Billion | ▲ +155.5% |
| 2015 | 0.67x | MX$11.90 Billion | MX$17.78 Billion | ▼ -50.8% |
| 2014 | 1.36x | MX$13.90 Billion | MX$10.21 Billion | — |